SFI
FBRX icon

Susquehanna Fundamental Investments’s Forte Biosciences FBRX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$48K Hold
1,308
– – ﹤0.01% 1492
2021
Q4 		$70K Hold
1,308
– – ﹤0.01% 1353
2021
Q3 		$97K Buy
+1,308
New +$725K ﹤0.01% 1627

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna Fundamental Investments's FBRX Position: Q1 2022 in Review

Susquehanna Fundamental Investments held its Forte Biosciences (FBRX) position steady in Q1 2022 at 1,308 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

Susquehanna Fundamental Investments first reported a position in FBRX in Q3 2021 and has held it in 3 quarters since. The position peaked at $97K in Q3 2021. 52 funds tracked by Wall St. Rank hold FBRX as of Q1 2022.

  • Susquehanna Fundamental Investments held 1,308 shares of Forte Biosciences worth $48K as of Q1 2022.
  • Susquehanna Fundamental Investments left its Forte Biosciences share count unchanged in Q1 2022.
  • Forte Biosciences made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1492 holding.
  • Susquehanna Fundamental Investments first reported a position in Forte Biosciences in Q3 2021 and has held it in 3 quarters since.
  • Susquehanna Fundamental Investments's Forte Biosciences position peaked at $97K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.